These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 28506283)

  • 1. Prolactin blocks the expression of receptor activator of nuclear factor κB ligand and reduces osteoclastogenesis and bone loss in murine inflammatory arthritis.
    Ledesma-Colunga MG; Adán N; Ortiz G; Solís-Gutiérrez M; López-Barrera F; Martínez de la Escalera G; Clapp C
    Arthritis Res Ther; 2017 May; 19(1):93. PubMed ID: 28506283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines.
    Naidu VG; Dinesh Babu KR; Thwin MM; Satish RL; Kumar PV; Gopalakrishnakone P
    Chem Biol Interact; 2013 Apr; 203(2):467-79. PubMed ID: 23333834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total Saponin from Anemone flaccida Fr. Schmidt Prevents Bone Destruction in Experimental Rheumatoid Arthritis via Inhibiting Osteoclastogenesis.
    Liu C; Yang Y; Sun D; Wang C; Wang H; Jia S; Liu L; Lin N
    Rejuvenation Res; 2015 Dec; 18(6):528-42. PubMed ID: 26418168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis.
    Kishimoto Y; Fukumoto S; Nishihara S; Mizumura H; Hirai K; Teshima R
    Rheumatology (Oxford); 2004 Dec; 43(12):1496-503. PubMed ID: 15353610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural flavonoid galangin inhibits osteoclastic bone destruction and osteoclastogenesis by suppressing NF-κB in collagen-induced arthritis and bone marrow-derived macrophages.
    Huh JE; Jung IT; Choi J; Baek YH; Lee JD; Park DS; Choi DY
    Eur J Pharmacol; 2013 Jan; 698(1-3):57-66. PubMed ID: 22985747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
    Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
    Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis.
    Li Y; Yang C; Jia K; Wang J; Wang J; Ming R; Xu T; Su X; Jing Y; Miao Y; Liu C; Lin N
    J Ethnopharmacol; 2022 Jan; 282():114602. PubMed ID: 34492323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis.
    Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB
    Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boldine isolated from Litsea cubeba inhibits bone resorption by suppressing the osteoclast differentiation in collagen-induced arthritis.
    Zhao H; Xu H; Qiao S; Lu C; Wang G; Liu M; Guo B; Tan Y; Ju D; Xiao C
    Int Immunopharmacol; 2017 Oct; 51():114-123. PubMed ID: 28826044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
    Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
    Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model.
    Atkinson SM; Bleil J; Maier R; Kühl AA; Thorn M; Serikawa K; Fox B; Kruse K; Haase C; Skov S; Nansen A; Syrbe U
    Arthritis Res Ther; 2016 Jan; 18():28. PubMed ID: 26801240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
    Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
    J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis.
    O'Brien W; Fissel BM; Maeda Y; Yan J; Ge X; Gravallese EM; Aliprantis AO; Charles JF
    Arthritis Rheumatol; 2016 Dec; 68(12):2889-2900. PubMed ID: 27563728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
    Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
    Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norisoboldine alleviates joint destruction in rats with adjuvant-induced arthritis by reducing RANKL, IL-6, PGE(2), and MMP-13 expression.
    Wei ZF; Jiao XL; Wang T; Lu Q; Xia YF; Wang ZT; Guo QL; Chou GX; Dai Y
    Acta Pharmacol Sin; 2013 Mar; 34(3):403-13. PubMed ID: 23396374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
    Chang CC; Tsai YH; Liu Y; Lin SY; Liang YC
    Rheumatology (Oxford); 2015 Oct; 54(10):1913-22. PubMed ID: 25998451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
    Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL
    J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon Monoxide Inhibits Receptor Activator of NF-κB (RANKL)-Induced Osteoclastogenesis.
    Tseng FJ; Chia WT; Wang CH; Shyu JF; Gou GH; Shui HA; Sytwu HK; Pan RY; Weng CF
    Cell Physiol Biochem; 2015; 36(3):1250-8. PubMed ID: 26138885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.